IFNA1 and cancer: Whereas reversing the hard lesions of MHC-I defects in cancers would require reintroduction of the lost or dysfunctional genes and thus would be difficult to achieve, the soft defects can be reversed by several approaches such IFN stimulation, inhibition of cancer cell signaling pathways that reduce MHC-I expression and epigenetic modifiers.